Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter CSAI Q4 2025 Earnings Loss per Share of 013 Amid Limited Disclosures MT Q1 2026 Earnings Modest EPS Beat Amid Revenue Uncertainty WWW Q1 2026 Earnings EPS Exceeds Estimates Positive Market Response TNON Q1 2026 Earnings NarrowerthanExpected EPS Loss Highlights Cost Discipline STLA Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally